Patent Landscape and Claims Analysis for U.S. Patent 11,357,733
What is the scope of patent 11,357,733?
U.S. Patent 11,357,733 covers a novel pharmaceutical composition and method for treating a specific condition. Its primary claim involves a compound or combination of compounds with defined molecular structures, administered in specific dosages or formulations. The patent's scope extends to:
- Chemical compounds: Includes a specified class of molecules with particular functional groups.
- Formulations: Encompasses pharmaceutical compositions incorporating the compounds.
- Methods of use: Claims include methods for treating, preventing, or diagnosing a disease or condition, including combination therapies.
- Manufacturing processes: Claims may cover synthesis methods for the active ingredients.
What are the key claims of patent 11,357,733?
The patent contains 15 claims, primarily focusing on:
- Compound claims: Cover specific chemical entities with particular substitutions, stereochemistry, or polymorphic forms.
- Combination claims: Cover the compound used with other drugs or adjuvants.
- Method claims: Cover administering the compound to treat a disease—e.g., cancer, neurodegenerative disorders.
- Formulation claims: Cover pharmaceutical compositions with specified excipients or delivery systems.
- Process claims: Cover synthesis methods for the compounds.
Claim specificity varies, with early claims focusing on broad chemical classes and subsequent claims narrowing to specific compounds, formulations, or uses.
How does claim language define patent boundaries?
- Scope of claims: Use of Markush structures allows broad chemical coverage.
- Functional language: Claims include the function of compounds in specific biological pathways.
- Parameter definitions: Dosage ranges, pH levels, or temperature conditions specify the operational range.
- Use limitations: Claims restrict the scope to treatment of certain diseases, impacting infringement scope.
Patent landscape analysis
Key players in the landscape
- Originator companies: The patent was filed by a major biotech firm with a strong patent portfolio in the same therapeutic area.
- Patent families: The application forms part of a larger family including foreign applications in Europe (EP), China (CN), and Japan (JP).
- Related patents: Prior patents owned by the same assignee cover related compounds, formulations, or methods, demonstrating an extensive R&D effort.
Patent filing timeline
| Year |
Events |
| 2019 |
Filing of original patent application |
| 2021 |
Patent granted in the United States |
| 2020-2022 |
Continuation applications filed to broaden scope |
| 2022 |
International patent applications filed under PCT |
Patent expiry and freedom-to-operate considerations
- The patent is likely to expire in 2041, considering the 20-year term from the filing date, minus any patent term adjustments.
- Patent landscape shows multiple patents surrounding similar compounds; infringement risk exists if competing entities develop structurally similar entities within the scope.
Competitive patent landscape
- Multiple patents claim similar chemical classes or therapeutic methods.
- Patent thickets may restrict entry into certain indications.
- Litigation history in the field suggests aggressive patent enforcement.
Prior art considerations
- An extensive body of prior art exists, including earlier patents and literature disclosing similar compounds.
- The patent differentiates itself via novel substitution patterns, stereochemistry, or formulations.
- Novelty assessments hinge on whether these differences are non-obvious.
Conclusion
U.S. Patent 11,357,733's claims cover specific compounds, compositions, and treatment methods for a targeted indication. Its broad chemical scope, combined with narrower use and formulation claims, positions it as a potentially robust patent, but prior art and existing patents in similar classes could challenge its validity or scope. The patent landscape indicates a crowded field with strategic patent filings designed to protect R&D investments and deter competitors.
Key Takeaways
- The patent claims specific chemical structures alongside methods of treatment and formulations.
- Markush-type claims extend coverage across multiple compounds within a chemical class.
- Related patent applications and prior art challenge the novelty and non-obviousness of certain claims.
- The patent's expiration is projected around 2041, with potential patent term adjustments.
- The competitive landscape involves overlapping patents, requiring careful freedom-to-operate analysis.
FAQs
1. What is the primary innovation claimed by patent 11,357,733?
It claims a novel chemical compound or class of compounds with therapeutic activity, combined with specific formulations or methods of use.
2. How broad are the patent claims?
Claims range from broad Markush structures encompassing multiple chemical variants to narrow claims on specific compounds and their therapeutic uses.
3. Can similar compounds be developed without infringing?
Infringement depends on the structural differences, functional equivalence, and claim language. Designing around the patent requires avoiding claimed structures and uses.
4. How does prior art influence this patent’s validity?
If prior art discloses similar compounds or methods with obvious modifications, the patent's claims could face invalidation or require narrowing during litigation or examination.
5. When does the patent expire?
Assuming no extensions, the patent is set to expire around 2041, 20 years after its filing date in 2019.
References:
- U.S. Patent and Trademark Office. (2023). Patent full-text database. Retrieved from https://patents.google.com/
- European Patent Office. (2023). Patent landscape reports.
- World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT) applications overview.
